Hepcidin Is Down-Regulated in Alcohol Loading
Background: It is common for alcoholic patients to have excess iron accumulation in the liver, which may contribute to the development of alcoholic liver disease (ALD). However, the mechanism of hepatic iron uptake in ALD is still obscure. Recently, a novel iron‐regulatory hormone hepcidin was found...
Saved in:
Published in | Alcoholism, clinical and experimental research Vol. 31; no. s1; pp. S2 - S8 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Malden, USA
Blackwell Publishing Inc
01.01.2007
|
Subjects | |
Online Access | Get full text |
ISSN | 0145-6008 1530-0277 1530-0277 |
DOI | 10.1111/j.1530-0277.2006.00279.x |
Cover
Loading…
Abstract | Background: It is common for alcoholic patients to have excess iron accumulation in the liver, which may contribute to the development of alcoholic liver disease (ALD). However, the mechanism of hepatic iron uptake in ALD is still obscure. Recently, a novel iron‐regulatory hormone hepcidin was found that suppresses the absorption of iron from the small intestine and the release of iron from macrophages. To elucidate the contribution of hepcidin toward the hepatic excess iron accumulation in ALD, we examined whether alcohol loading affects hepcidin expression both in ALD patients and in an ethanol‐fed mouse model.
Methods: Serum prohepcidin concentration was quantified by enzyme‐linked immunosorbent assay. Hepatic hepcidin‐1 and hepcidin‐2 mRNA expressions in mouse liver were evaluated by quantitative real‐time reverse‐transcriptase polymerase chain reaction method. The protein expression of prohepcidin in mouse liver was examined immunohistochemically by rabbit antimouse prohepcidin antibody.
Results: Serum prohepcidin concentration in ALD was significantly lower than that in healthy subjects (p<0.001). Especially, serum prohepcidin concentrations were decreased in the patients whose serum ferritin value was high. In the ethanol‐fed mouse model, hepatic hepcidin‐1 mRNA expression was significantly lower than that in control (p=0.04). Prohepcidin was expressed in the cytoplasm of hepatocytes of mice liver tissue sections, and its expression was decreased after ethanol loading.
Conclusion: Alcohol loading down‐regulates hepatic hepcidin expression and leads to the increase of iron absorption from the intestine. |
---|---|
AbstractList | It is common for alcoholic patients to have excess iron accumulation in the liver, which may contribute to the development of alcoholic liver disease (ALD). However, the mechanism of hepatic iron uptake in ALD is still obscure. Recently, a novel iron-regulatory hormone hepcidin was found that suppresses the absorption of iron from the small intestine and the release of iron from macrophages. To elucidate the contribution of hepcidin toward the hepatic excess iron accumulation in ALD, we examined whether alcohol loading affects hepcidin expression both in ALD patients and in an ethanol-fed mouse model.BACKGROUNDIt is common for alcoholic patients to have excess iron accumulation in the liver, which may contribute to the development of alcoholic liver disease (ALD). However, the mechanism of hepatic iron uptake in ALD is still obscure. Recently, a novel iron-regulatory hormone hepcidin was found that suppresses the absorption of iron from the small intestine and the release of iron from macrophages. To elucidate the contribution of hepcidin toward the hepatic excess iron accumulation in ALD, we examined whether alcohol loading affects hepcidin expression both in ALD patients and in an ethanol-fed mouse model.Serum prohepcidin concentration was quantified by enzyme-linked immunosorbent assay. Hepatic hepcidin-1 and hepcidin-2 mRNA expressions in mouse liver were evaluated by quantitative real-time reverse-transcriptase polymerase chain reaction method. The protein expression of prohepcidin in mouse liver was examined immunohistochemically by rabbit antimouse prohepcidin antibody.METHODSSerum prohepcidin concentration was quantified by enzyme-linked immunosorbent assay. Hepatic hepcidin-1 and hepcidin-2 mRNA expressions in mouse liver were evaluated by quantitative real-time reverse-transcriptase polymerase chain reaction method. The protein expression of prohepcidin in mouse liver was examined immunohistochemically by rabbit antimouse prohepcidin antibody.Serum prohepcidin concentration in ALD was significantly lower than that in healthy subjects (p<0.001). Especially, serum prohepcidin concentrations were decreased in the patients whose serum ferritin value was high. In the ethanol-fed mouse model, hepatic hepcidin-1 mRNA expression was significantly lower than that in control (p=0.04). Prohepcidin was expressed in the cytoplasm of hepatocytes of mice liver tissue sections, and its expression was decreased after ethanol loading.RESULTSSerum prohepcidin concentration in ALD was significantly lower than that in healthy subjects (p<0.001). Especially, serum prohepcidin concentrations were decreased in the patients whose serum ferritin value was high. In the ethanol-fed mouse model, hepatic hepcidin-1 mRNA expression was significantly lower than that in control (p=0.04). Prohepcidin was expressed in the cytoplasm of hepatocytes of mice liver tissue sections, and its expression was decreased after ethanol loading.Alcohol loading down-regulates hepatic hepcidin expression and leads to the increase of iron absorption from the intestine.CONCLUSIONAlcohol loading down-regulates hepatic hepcidin expression and leads to the increase of iron absorption from the intestine. Background: It is common for alcoholic patients to have excess iron accumulation in the liver, which may contribute to the development of alcoholic liver disease (ALD). However, the mechanism of hepatic iron uptake in ALD is still obscure. Recently, a novel iron‐regulatory hormone hepcidin was found that suppresses the absorption of iron from the small intestine and the release of iron from macrophages. To elucidate the contribution of hepcidin toward the hepatic excess iron accumulation in ALD, we examined whether alcohol loading affects hepcidin expression both in ALD patients and in an ethanol‐fed mouse model. Methods: Serum prohepcidin concentration was quantified by enzyme‐linked immunosorbent assay. Hepatic hepcidin‐1 and hepcidin‐2 mRNA expressions in mouse liver were evaluated by quantitative real‐time reverse‐transcriptase polymerase chain reaction method. The protein expression of prohepcidin in mouse liver was examined immunohistochemically by rabbit antimouse prohepcidin antibody. Results: Serum prohepcidin concentration in ALD was significantly lower than that in healthy subjects (p<0.001). Especially, serum prohepcidin concentrations were decreased in the patients whose serum ferritin value was high. In the ethanol‐fed mouse model, hepatic hepcidin‐1 mRNA expression was significantly lower than that in control (p=0.04). Prohepcidin was expressed in the cytoplasm of hepatocytes of mice liver tissue sections, and its expression was decreased after ethanol loading. Conclusion: Alcohol loading down‐regulates hepatic hepcidin expression and leads to the increase of iron absorption from the intestine. It is common for alcoholic patients to have excess iron accumulation in the liver, which may contribute to the development of alcoholic liver disease (ALD). However, the mechanism of hepatic iron uptake in ALD is still obscure. Recently, a novel iron-regulatory hormone hepcidin was found that suppresses the absorption of iron from the small intestine and the release of iron from macrophages. To elucidate the contribution of hepcidin toward the hepatic excess iron accumulation in ALD, we examined whether alcohol loading affects hepcidin expression both in ALD patients and in an ethanol-fed mouse model. Serum prohepcidin concentration was quantified by enzyme-linked immunosorbent assay. Hepatic hepcidin-1 and hepcidin-2 mRNA expressions in mouse liver were evaluated by quantitative real-time reverse-transcriptase polymerase chain reaction method. The protein expression of prohepcidin in mouse liver was examined immunohistochemically by rabbit antimouse prohepcidin antibody. Serum prohepcidin concentration in ALD was significantly lower than that in healthy subjects (p<0.001). Especially, serum prohepcidin concentrations were decreased in the patients whose serum ferritin value was high. In the ethanol-fed mouse model, hepatic hepcidin-1 mRNA expression was significantly lower than that in control (p=0.04). Prohepcidin was expressed in the cytoplasm of hepatocytes of mice liver tissue sections, and its expression was decreased after ethanol loading. Alcohol loading down-regulates hepatic hepcidin expression and leads to the increase of iron absorption from the intestine. Background: It is common for alcoholic patients to have excess iron accumulation in the liver, which may contribute to the development of alcoholic liver disease (ALD). However, the mechanism of hepatic iron uptake in ALD is still obscure. Recently, a novel iron‐regulatory hormone hepcidin was found that suppresses the absorption of iron from the small intestine and the release of iron from macrophages. To elucidate the contribution of hepcidin toward the hepatic excess iron accumulation in ALD, we examined whether alcohol loading affects hepcidin expression both in ALD patients and in an ethanol‐fed mouse model. Methods: Serum prohepcidin concentration was quantified by enzyme‐linked immunosorbent assay. Hepatic hepcidin‐1 and hepcidin‐2 mRNA expressions in mouse liver were evaluated by quantitative real‐time reverse‐transcriptase polymerase chain reaction method. The protein expression of prohepcidin in mouse liver was examined immunohistochemically by rabbit antimouse prohepcidin antibody. Results: Serum prohepcidin concentration in ALD was significantly lower than that in healthy subjects ( p <0.001). Especially, serum prohepcidin concentrations were decreased in the patients whose serum ferritin value was high. In the ethanol‐fed mouse model, hepatic hepcidin‐1 mRNA expression was significantly lower than that in control ( p =0.04). Prohepcidin was expressed in the cytoplasm of hepatocytes of mice liver tissue sections, and its expression was decreased after ethanol loading. Conclusion: Alcohol loading down‐regulates hepatic hepcidin expression and leads to the increase of iron absorption from the intestine. |
Author | Ohtake, Takaaki Saito, Hiroyuki Kohgo, Yutaka Fujimoto, Yoshinori Inoue, Mitsutaka Hosoki, Yayoi Suzuki, Yasuaki Miyoshi, Shigeki |
Author_xml | – sequence: 1 givenname: Takaaki surname: Ohtake fullname: Ohtake, Takaaki organization: Third Department of Internal Medicine, Asahikawa Medical College, Asahikawa 078-8510, Japan – sequence: 2 givenname: Hiroyuki surname: Saito fullname: Saito, Hiroyuki organization: Third Department of Internal Medicine, Asahikawa Medical College, Asahikawa 078-8510, Japan – sequence: 3 givenname: Yayoi surname: Hosoki fullname: Hosoki, Yayoi organization: Third Department of Internal Medicine, Asahikawa Medical College, Asahikawa 078-8510, Japan – sequence: 4 givenname: Mitsutaka surname: Inoue fullname: Inoue, Mitsutaka organization: Third Department of Internal Medicine, Asahikawa Medical College, Asahikawa 078-8510, Japan – sequence: 5 givenname: Shigeki surname: Miyoshi fullname: Miyoshi, Shigeki organization: Third Department of Internal Medicine, Asahikawa Medical College, Asahikawa 078-8510, Japan – sequence: 6 givenname: Yasuaki surname: Suzuki fullname: Suzuki, Yasuaki organization: Third Department of Internal Medicine, Asahikawa Medical College, Asahikawa 078-8510, Japan – sequence: 7 givenname: Yoshinori surname: Fujimoto fullname: Fujimoto, Yoshinori organization: Department of Internal Medicine, Furano Hospital of Hokkaido Social Service Association, Furano 076-0024, Japan – sequence: 8 givenname: Yutaka surname: Kohgo fullname: Kohgo, Yutaka organization: Third Department of Internal Medicine, Asahikawa Medical College, Asahikawa 078-8510, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17331161$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkMtOwzAQRS0Eghb4BZQVu4Rx7MTJAqSqlJeqghCP5ch1HHBJ4xKnov17XApdsAFvPPLccz1zu2S7trUmJKAQUX9OJhFNGIQQCxHFAGkEvsyjxRbpbBrbpAOUJ2EKkO2RrnMTAOBZmu6SPSoYozSlHRJe6ZkyhamDaxec2486vNcv80q2ugj8Y69S9tVWwdBKr3k5IDulrJw-_L73yePF4KF_FQ5vL6_7vWGouKB5KHLGISv8SDrRgnNOx4Wmca4BWJllMuY5L0Wap7GgivouTwqelDkbF-O8VIrtk-O176yx73PtWpwap3RVyVrbuUMBcRxDxr3w6Fs4H091gbPGTGWzxJ8FveBsLVCNda7RJSrTytbYum2kqZACrhLFCa6Cw1VwuEoUvxLFhTfIfhls_vgbPV2jH6bSy39z2OsP7n3l-XDNG9fqxYaXzRumgokEn0eXeHczgqe7iyGO2CdL1pk1 |
CitedBy_id | crossref_primary_10_1177_0748233710387007 crossref_primary_10_1016_j_clnu_2018_05_008 crossref_primary_10_1016_j_fbio_2022_101794 crossref_primary_10_1080_13547500802033391 crossref_primary_10_1128_MCB_00723_12 crossref_primary_10_1111_j_1440_1746_2007_05290_x crossref_primary_10_1182_blood_2010_01_261875 crossref_primary_10_1093_ajcn_nqab165 crossref_primary_10_1007_s00204_021_03166_1 crossref_primary_10_1016_j_bcmd_2016_06_008 crossref_primary_10_1155_2012_459278 crossref_primary_10_3389_fonc_2022_940552 crossref_primary_10_1007_s00432_009_0585_5 crossref_primary_10_3390_molecules26247437 crossref_primary_10_1111_acer_15520 crossref_primary_10_2174_1570163817666200121143959 crossref_primary_10_3389_fpsyt_2023_1230406 crossref_primary_10_1093_toxsci_kfs176 crossref_primary_10_1080_00365521_2024_2314707 crossref_primary_10_1016_j_ymgme_2019_01_004 crossref_primary_10_1155_2020_7373498 crossref_primary_10_1016_j_tox_2015_11_001 crossref_primary_10_1097_BS9_0000000000000099 crossref_primary_10_1111_j_1440_1746_2011_07014_x crossref_primary_10_3748_wjg_v25_i5_521 crossref_primary_10_1016_j_revmed_2007_05_005 crossref_primary_10_1309_LMF28S2GIMXNWHMM crossref_primary_10_3390_biom5020793 crossref_primary_10_1111_j_1872_034X_2008_00442_x crossref_primary_10_2147_JHC_S450460 crossref_primary_10_1111_j_1530_0277_2011_01677_x crossref_primary_10_1186_1472_6920_10_33 crossref_primary_10_3390_nu15194105 crossref_primary_10_3748_wjg_v20_i34_12161 crossref_primary_10_3748_wjg_v29_i4_616 crossref_primary_10_1016_j_ajpath_2021_04_005 crossref_primary_10_3748_wjg_15_1186 crossref_primary_10_1016_j_jhep_2019_05_003 crossref_primary_10_1016_j_metabol_2012_06_008 crossref_primary_10_3350_kjhep_2010_16_3_288 crossref_primary_10_1139_bcb_2017_0206 crossref_primary_10_1111_j_1530_0277_2008_00782_x crossref_primary_10_1002_ajh_23110 crossref_primary_10_1097_MEG_0b013e328355cfd0 crossref_primary_10_3390_nu14010132 crossref_primary_10_1007_s00535_016_1237_6 crossref_primary_10_1093_jrr_rrv098 crossref_primary_10_3109_10408363_2010_550461 crossref_primary_10_1002_ajh_23714 crossref_primary_10_1093_alcalc_agt138 crossref_primary_10_4254_wjh_v2_i8_302 crossref_primary_10_1007_s12011_019_01887_0 crossref_primary_10_1371_journal_pmed_1004039 crossref_primary_10_1016_j_ymgme_2019_05_003 crossref_primary_10_3390_foods11131881 crossref_primary_10_1016_j_jnutbio_2014_02_009 crossref_primary_10_1053_j_gastro_2007_11_048 crossref_primary_10_1002_humu_22396 crossref_primary_10_1039_C4MT00225C crossref_primary_10_1007_s11033_010_0180_5 crossref_primary_10_1007_s10238_009_0062_0 crossref_primary_10_1042_CS20230522 crossref_primary_10_1111_1440_1681_13445 crossref_primary_10_1111_acer_13754 crossref_primary_10_1007_s00109_022_02254_8 crossref_primary_10_1152_physrev_00008_2013 crossref_primary_10_1002_bdra_20729 crossref_primary_10_1159_000471838 crossref_primary_10_1111_j_1530_0277_2009_00969_x crossref_primary_10_1152_ajpgi_90550_2008 crossref_primary_10_1016_j_clinre_2011_01_017 crossref_primary_10_1016_j_toxrep_2015_01_004 |
Cites_doi | 10.1002/hep.20663 10.1074/jbc.M205305200 10.1016/j.jhep.2005.02.047 10.1046/j.1365-2141.2003.04516.x 10.1126/science.1104742 10.1172/JCI0215686 10.1182/blood-2002-10-3235 10.1038/ng1150 10.1182/blood-2003-07-2524 10.1074/jbc.M008923200 10.1111/acer.1998.22.s3_part1.145s 10.1016/S0140-6736(03)12602-5 10.1016/S0014-5793(00)01920-7 10.1515/CCLM.2004.069 10.1097/01.alc.0000189274.00479.62 10.1007/BF02255967 10.1182/blood-2003-03-0672 10.1073/pnas.151179498 10.1111/j.1530-0277.2002.tb02698.x 10.1172/JCI200420945 10.1074/jbc.M008922200 10.1111/j.1530-0277.2004.tb03225.x 10.1053/j.gastro.2004.11.057 10.1016/S0026-0495(03)00277-4 10.1073/pnas.0409808102 10.1002/hep.20620 10.1002/hep.1840220441 10.1182/blood-2004-04-1416 10.1182/blood-2004-08-3042 10.1172/JCI118077 10.1111/j.1530-0277.1996.tb01134.x |
ContentType | Journal Article |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/j.1530-0277.2006.00279.x |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Social Welfare & Social Work |
EISSN | 1530-0277 |
EndPage | S8 |
ExternalDocumentID | 17331161 10_1111_j_1530_0277_2006_00279_x ACER279 ark_67375_WNG_PJN0VPFL_N |
Genre | article Journal Article |
GroupedDBID | --- -ET -~X .3N .55 .GA .Y3 05W 08G 0R~ 10A 1OB 1OC 23M 31~ 33P 36B 3SF 4.4 4Q1 4Q2 4Q3 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 A8Z AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABIVO ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBIZ ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFTRI AFUWQ AFZJQ AHBTC AHEFC AHMBA AHRYX AI. AIACR AIAGR AITYG AIURR AIWBW AIZYK AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AWKKM AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO EBD EBS EJD EMB EMOBN EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IX1 J0M K48 KBYEO KMI L89 LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NTWIH O66 O9- OAG OAH OIG OL1 OMB OPX OVD OWU OWV OWW OWX OWY OWZ P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SJN SUPJJ SV3 TEORI TWZ UAP UB1 VH1 VVN W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 XSW XYM YFH ZFV ZGI ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ BYPQX AAYXX AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c4719-793408d279e5e74441bde129e003f88a2494f7696271c141b45d45f93bdb9fcc3 |
IEDL.DBID | DR2 |
ISSN | 0145-6008 1530-0277 |
IngestDate | Fri Jul 11 07:26:23 EDT 2025 Wed Feb 19 01:44:30 EST 2025 Thu Apr 24 22:52:58 EDT 2025 Tue Jul 01 04:01:31 EDT 2025 Wed Jan 22 16:17:38 EST 2025 Wed Oct 30 09:55:52 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | s1 |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4719-793408d279e5e74441bde129e003f88a2494f7696271c141b45d45f93bdb9fcc3 |
Notes | istex:25A26C1E0598F5A982431628EDDA93C93DF5C49A ArticleID:ACER279 ark:/67375/WNG-PJN0VPFL-N ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 17331161 |
PQID | 70222084 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_70222084 pubmed_primary_17331161 crossref_citationtrail_10_1111_j_1530_0277_2006_00279_x crossref_primary_10_1111_j_1530_0277_2006_00279_x wiley_primary_10_1111_j_1530_0277_2006_00279_x_ACER279 istex_primary_ark_67375_WNG_PJN0VPFL_N |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007-01 January 2007 2007-01-00 2007-Jan 20070101 |
PublicationDateYYYYMMDD | 2007-01-01 |
PublicationDate_xml | – month: 01 year: 2007 text: 2007-01 |
PublicationDecade | 2000 |
PublicationPlace | Malden, USA |
PublicationPlace_xml | – name: Malden, USA – name: England |
PublicationTitle | Alcoholism, clinical and experimental research |
PublicationTitleAlternate | Alcohol Clin Exp Res |
PublicationYear | 2007 |
Publisher | Blackwell Publishing Inc |
Publisher_xml | – name: Blackwell Publishing Inc |
References | Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Hosoki Y, Saito H, Kato J (2005) Iron accumulation in alcoholic liver diseases. Alcohol Clin Exp Res 29:189S-193S. Wallace DF, Summerville L, Lusby PE, Subramaniam VN (2005) Prohepcidin localises to the Golgi compartment and secretory pathway in hepatocytes. J Hepatol 43:720-728. Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783-788. Mazur A, Feillet-Coudray C, Romier B, Bayle D, Gueux E, Ruivard M, Coudray C, Rayssiguier Y (2003) Dietary iron regulates hepatic hepcidin 1 and 2 mRNAs in mice. Metabolism 52:1229-1231. Duane P, Raja KB, Simpson RJ, Peters TJ (1992) Intestinal iron absorption in chronic alcoholics. Alcohol Alcohol 27:539-544. Takada A, Takase S, Tsutsumi M (1993) Characteristic features of alcoholic liver disease in Japan: a review. Gastroenterol Jpn 28:137-148. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004a) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093. Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806-7810. Valerio LG Jr, Parks T, Petersen DR (1996) Alcohol mediates increases in hepatic and serum nonheme iron stores in a rat model for alcohol-induced liver injury. Alcohol Clin Exp Res 20:1352-1361. Taes YE, Wuyts B, Boelaert JR, De Vriese AS, Delanghe JR (2004) Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med 42:387-389. Nicolas G, Viatte L, Lou DQ, Bennoun M, Beaumont C, Kahn A, Andrews NC, Vaulont S (2003) Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 34:97-101. Brissot P, Bourel M, Herry D, Verger JP, Messner M, Beaumont C, Regnouard F, Ferrand B, Simon M (1981) Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 80:557-565. Montosi G, Corradini E, Garuti C, Barelli S, Recalcati S, Cairo G, Valli L, Pignatti E, Vecchi C, Ferrara F, Pietrangelo A (2005) Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload. Hepatology 41:545-552. Hunter HN, Fulton DB, Ganz T, Vogel HJ (2002) The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 277:37597-37603. Dallalio G, Fleury T, Means RT (2003) Serum hepcidin in clinical specimens. Br J Haematol 122:996-1000. French SW (2001) Intragastic ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J Biomed Sci 8:20-27. Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, O'Kelly J, Umehara Y, Wano Y, Said JW, Koeffler HP (2005) Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 105:376-381. Tsukamoto H, Horne W, Kamimura S, Niemela O, Parkkila S, Yla-Herttuala S, Brittenham GM (1995) Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96:620-630. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:2461-2463. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S (2002) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110:1037-1044. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 98:8780-8785. Pietrangelo A, Caleffi A, Henrion J, Ferrara F, Corradini E, Kulaksiz H, Stremmel W, Andreone P, Garuti C (2005) Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. Gastroenterology 128:470-479. Ohhira M, Ohtake T, Matsumoto A, Saito H, Ikuta K, Fujimoto Y, Ono M, Toyokuni S, Kohgo Y (1998) Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases. Alcohol Clin Exp Res 22:145S-149S. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulze-Knoppe P, Adermann K (2000) LEAP-1, a novel highly disulfided-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480:147-150. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T (2004b) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271-1276. Xiong S, She H, Sung CK, Tsukamoto H (2003) Iron-dependent activation of NF-kappaB in Kupffer cells: a priming mechanism for alcoholic liver disease. Alcohol 30:107-113. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811-7819. Kamimura S, Tsukamoto H (1995) Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 22:1304-1309. Lou DQ, Nicolas G, Lesbordes JC, Viatte L, Grimber G, Szajnert MF, Kahn A, Vaulont S (2004) Functional differences between hepcidin 1 and 2 in transgenic mice. Blood 103:2816-2821. Lou DQ, Lesbordes JC, Nicolas G, Viatte L, Bennoun M, Van Rooijen N, Kahn A, Renia L, Vaulont S (2005) Iron- and inflammation-induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo. Hepatology 41:1056-1064. Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, Stremmel W (2004) Pro-hepcidin: expression and cell specific localization in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 53:735-743. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C (2005) Hepcidin is decreased in TFR2 hemochromatosis. Blood 105:1803-1806. Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, Subramaniam VN, Powell LW, Anderson GJ, Ramm GA (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361:669-673. Suzuki M, Fujimoto Y, Suzuki Y, Hosoki Y, Saito H, Nakayama K, Ohtake T, Kohgo Y (2004) Induction of transferrin receptor by ethanol in rat primary hepatocyte culture. Alcohol Clin Exp Res 28:98S-105S. Lee P, Peng H, Gelbart T, Wang L, Beutler E (2005) Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A 102:1906-1910. Suzuki Y, Saito H, Suzuki M, Hosoki Y, Sakurai S, Fujimoto Y, Kohgo Y (2002) Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease. Alcohol Clin Exp Res 26:26S-31S. 1995; 96 2004; 42 2004; 103 1993; 28 2002; 110 2004; 28 2002; 277 2005; 41 2005; 43 2005; 29 2003; 52 2003; 30 1998; 22 2003; 34 2001; 276 2004; 53 2002; 26 1981; 80 2005; 102 2004a; 306 1995; 22 2005; 105 2001; 8 2005; 128 2000; 480 1992; 27 2003; 102 2003; 101 2003; 122 2004b; 113 1996; 20 2003; 361 2001; 98 e_1_2_5_27_1 Xiong S (e_1_2_5_37_1) 2003; 30 e_1_2_5_28_1 e_1_2_5_25_1 e_1_2_5_26_1 e_1_2_5_23_1 e_1_2_5_24_1 e_1_2_5_21_1 e_1_2_5_22_1 e_1_2_5_29_1 Brissot P (e_1_2_5_3_1) 1981; 80 e_1_2_5_20_1 e_1_2_5_15_1 e_1_2_5_14_1 e_1_2_5_17_1 e_1_2_5_36_1 e_1_2_5_9_1 e_1_2_5_16_1 e_1_2_5_8_1 e_1_2_5_11_1 e_1_2_5_34_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_35_1 e_1_2_5_6_1 e_1_2_5_32_1 e_1_2_5_12_1 e_1_2_5_4_1 e_1_2_5_2_1 e_1_2_5_19_1 e_1_2_5_18_1 Takada A (e_1_2_5_33_1) 1993; 28 e_1_2_5_30_1 Kulaksiz H (e_1_2_5_13_1) 2004; 53 e_1_2_5_31_1 Duane P (e_1_2_5_5_1) 1992; 27 |
References_xml | – reference: Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Hosoki Y, Saito H, Kato J (2005) Iron accumulation in alcoholic liver diseases. Alcohol Clin Exp Res 29:189S-193S. – reference: Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C (2005) Hepcidin is decreased in TFR2 hemochromatosis. Blood 105:1803-1806. – reference: Dallalio G, Fleury T, Means RT (2003) Serum hepcidin in clinical specimens. Br J Haematol 122:996-1000. – reference: Valerio LG Jr, Parks T, Petersen DR (1996) Alcohol mediates increases in hepatic and serum nonheme iron stores in a rat model for alcohol-induced liver injury. Alcohol Clin Exp Res 20:1352-1361. – reference: Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811-7819. – reference: Brissot P, Bourel M, Herry D, Verger JP, Messner M, Beaumont C, Regnouard F, Ferrand B, Simon M (1981) Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 80:557-565. – reference: Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806-7810. – reference: Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, O'Kelly J, Umehara Y, Wano Y, Said JW, Koeffler HP (2005) Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 105:376-381. – reference: Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, Subramaniam VN, Powell LW, Anderson GJ, Ramm GA (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361:669-673. – reference: Taes YE, Wuyts B, Boelaert JR, De Vriese AS, Delanghe JR (2004) Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med 42:387-389. – reference: Xiong S, She H, Sung CK, Tsukamoto H (2003) Iron-dependent activation of NF-kappaB in Kupffer cells: a priming mechanism for alcoholic liver disease. Alcohol 30:107-113. – reference: Nicolas G, Viatte L, Lou DQ, Bennoun M, Beaumont C, Kahn A, Andrews NC, Vaulont S (2003) Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 34:97-101. – reference: French SW (2001) Intragastic ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J Biomed Sci 8:20-27. – reference: Montosi G, Corradini E, Garuti C, Barelli S, Recalcati S, Cairo G, Valli L, Pignatti E, Vecchi C, Ferrara F, Pietrangelo A (2005) Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload. Hepatology 41:545-552. – reference: Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 98:8780-8785. – reference: Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulze-Knoppe P, Adermann K (2000) LEAP-1, a novel highly disulfided-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480:147-150. – reference: Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S (2002) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110:1037-1044. – reference: Hunter HN, Fulton DB, Ganz T, Vogel HJ (2002) The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 277:37597-37603. – reference: Duane P, Raja KB, Simpson RJ, Peters TJ (1992) Intestinal iron absorption in chronic alcoholics. Alcohol Alcohol 27:539-544. – reference: Lou DQ, Nicolas G, Lesbordes JC, Viatte L, Grimber G, Szajnert MF, Kahn A, Vaulont S (2004) Functional differences between hepcidin 1 and 2 in transgenic mice. Blood 103:2816-2821. – reference: Takada A, Takase S, Tsutsumi M (1993) Characteristic features of alcoholic liver disease in Japan: a review. Gastroenterol Jpn 28:137-148. – reference: Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783-788. – reference: Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004a) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093. – reference: Ohhira M, Ohtake T, Matsumoto A, Saito H, Ikuta K, Fujimoto Y, Ono M, Toyokuni S, Kohgo Y (1998) Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases. Alcohol Clin Exp Res 22:145S-149S. – reference: Kamimura S, Tsukamoto H (1995) Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 22:1304-1309. – reference: Mazur A, Feillet-Coudray C, Romier B, Bayle D, Gueux E, Ruivard M, Coudray C, Rayssiguier Y (2003) Dietary iron regulates hepatic hepcidin 1 and 2 mRNAs in mice. Metabolism 52:1229-1231. – reference: Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T (2004b) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271-1276. – reference: Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:2461-2463. – reference: Pietrangelo A, Caleffi A, Henrion J, Ferrara F, Corradini E, Kulaksiz H, Stremmel W, Andreone P, Garuti C (2005) Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. Gastroenterology 128:470-479. – reference: Lou DQ, Lesbordes JC, Nicolas G, Viatte L, Bennoun M, Van Rooijen N, Kahn A, Renia L, Vaulont S (2005) Iron- and inflammation-induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo. Hepatology 41:1056-1064. – reference: Suzuki Y, Saito H, Suzuki M, Hosoki Y, Sakurai S, Fujimoto Y, Kohgo Y (2002) Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease. Alcohol Clin Exp Res 26:26S-31S. – reference: Tsukamoto H, Horne W, Kamimura S, Niemela O, Parkkila S, Yla-Herttuala S, Brittenham GM (1995) Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96:620-630. – reference: Lee P, Peng H, Gelbart T, Wang L, Beutler E (2005) Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A 102:1906-1910. – reference: Wallace DF, Summerville L, Lusby PE, Subramaniam VN (2005) Prohepcidin localises to the Golgi compartment and secretory pathway in hepatocytes. J Hepatol 43:720-728. – reference: Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, Stremmel W (2004) Pro-hepcidin: expression and cell specific localization in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 53:735-743. – reference: Suzuki M, Fujimoto Y, Suzuki Y, Hosoki Y, Saito H, Nakayama K, Ohtake T, Kohgo Y (2004) Induction of transferrin receptor by ethanol in rat primary hepatocyte culture. Alcohol Clin Exp Res 28:98S-105S. – volume: 98 start-page: 8780 year: 2001 end-page: 8785 article-title: Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice publication-title: Proc Natl Acad Sci U S A – volume: 28 start-page: 137 year: 1993 end-page: 148 article-title: Characteristic features of alcoholic liver disease in Japan publication-title: a review – volume: 43 start-page: 720 year: 2005 end-page: 728 article-title: Prohepcidin localises to the Golgi compartment and secretory pathway in hepatocytes publication-title: J Hepatol – volume: 22 start-page: 1304 year: 1995 end-page: 1309 article-title: Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease publication-title: Hepatology – volume: 29 start-page: 189S year: 2005 end-page: 193S article-title: Iron accumulation in alcoholic liver diseases publication-title: Alcohol Clin Exp Res – volume: 102 start-page: 1906 year: 2005 end-page: 1910 article-title: Regulation of hepcidin transcription by interleukin‐1 and interleukin‐6 publication-title: Proc Natl Acad Sci U S A – volume: 34 start-page: 97 year: 2003 end-page: 101 article-title: Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis publication-title: Nat Genet – volume: 26 start-page: 26S year: 2002 end-page: 31S article-title: Up‐regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease publication-title: Alcohol Clin Exp Res – volume: 8 start-page: 20 year: 2001 end-page: 27 article-title: Intragastic ethanol infusion model for cellular and molecular studies of alcoholic liver disease publication-title: J Biomed Sci – volume: 103 start-page: 2816 year: 2004 end-page: 2821 article-title: Functional differences between hepcidin 1 and 2 in transgenic mice publication-title: Blood – volume: 96 start-page: 620 year: 1995 end-page: 630 article-title: Experimental liver cirrhosis induced by alcohol and iron publication-title: J Clin Invest – volume: 52 start-page: 1229 year: 2003 end-page: 1231 article-title: Dietary iron regulates hepatic hepcidin 1 and 2 mRNAs in mice publication-title: Metabolism – volume: 53 start-page: 735 year: 2004 end-page: 743 article-title: Pro‐hepcidin publication-title: expression and cell specific localization in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia – volume: 105 start-page: 1803 year: 2005 end-page: 1806 article-title: Hepcidin is decreased in TFR2 hemochromatosis publication-title: Blood – volume: 20 start-page: 1352 year: 1996 end-page: 1361 article-title: Alcohol mediates increases in hepatic and serum nonheme iron stores in a rat model for alcohol‐induced liver injury publication-title: Alcohol Clin Exp Res – volume: 102 start-page: 783 year: 2003 end-page: 788 article-title: Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation publication-title: Blood – volume: 480 start-page: 147 year: 2000 end-page: 150 article-title: LEAP‐1, a novel highly disulfided‐bonded human peptide, exhibits antimicrobial activity publication-title: FEBS Lett – volume: 27 start-page: 539 year: 1992 end-page: 544 article-title: Intestinal iron absorption in chronic alcoholics publication-title: Alcohol Alcohol – volume: 110 start-page: 1037 year: 2002 end-page: 1044 article-title: The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation publication-title: J Clin Invest – volume: 276 start-page: 7806 year: 2001 end-page: 7810 article-title: Hepcidin, a urinary antimicrobial peptide synthesized in the liver publication-title: J Biol Chem – volume: 277 start-page: 37597 year: 2002 end-page: 37603 article-title: The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis publication-title: J Biol Chem – volume: 105 start-page: 376 year: 2005 end-page: 381 article-title: Expression of hepcidin is down‐regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis publication-title: Blood – volume: 42 start-page: 387 year: 2004 end-page: 389 article-title: Prohepcidin accumulates in renal insufficiency publication-title: Clin Chem Lab Med – volume: 113 start-page: 1271 year: 2004b end-page: 1276 article-title: IL‐6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin publication-title: J Clin Invest – volume: 28 start-page: 98S year: 2004 end-page: 105S article-title: Induction of transferrin receptor by ethanol in rat primary hepatocyte culture publication-title: Alcohol Clin Exp Res – volume: 80 start-page: 557 year: 1981 end-page: 565 article-title: Assessment of liver iron content in 271 patients publication-title: a reevaluation of direct and indirect methods – volume: 122 start-page: 996 year: 2003 end-page: 1000 article-title: Serum hepcidin in clinical specimens publication-title: Br J Haematol – volume: 101 start-page: 2461 year: 2003 end-page: 2463 article-title: Hepcidin, a putative mediator of anemia of inflammation, is a type II acute‐phase protein publication-title: Blood – volume: 41 start-page: 545 year: 2005 end-page: 552 article-title: Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload publication-title: Hepatology – volume: 128 start-page: 470 year: 2005 end-page: 479 article-title: Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes publication-title: Gastroenterology – volume: 306 start-page: 2090 year: 2004a end-page: 2093 article-title: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization publication-title: Science – volume: 22 start-page: 145S year: 1998 end-page: 149S article-title: Immunohistochemical detection of 4‐hydroxy‐2‐nonenal‐modified‐protein adducts in human alcoholic liver diseases publication-title: Alcohol Clin Exp Res – volume: 30 start-page: 107 year: 2003 end-page: 113 article-title: Iron‐dependent activation of NF‐kappaB in Kupffer cells publication-title: a priming mechanism for alcoholic liver disease – volume: 276 start-page: 7811 year: 2001 end-page: 7819 article-title: A new mouse liver‐specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload publication-title: J Biol Chem – volume: 361 start-page: 669 year: 2003 end-page: 673 article-title: Disrupted hepcidin regulation in HFE‐associated haemochromatosis and the liver as a regulator of body iron homoeostasis publication-title: Lancet – volume: 41 start-page: 1056 year: 2005 end-page: 1064 article-title: Iron‐ and inflammation‐induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo publication-title: Hepatology – volume: 27 start-page: 539 year: 1992 ident: e_1_2_5_5_1 article-title: Intestinal iron absorption in chronic alcoholics publication-title: Alcohol Alcohol – ident: e_1_2_5_15_1 doi: 10.1002/hep.20663 – ident: e_1_2_5_8_1 doi: 10.1074/jbc.M205305200 – ident: e_1_2_5_36_1 doi: 10.1016/j.jhep.2005.02.047 – volume: 80 start-page: 557 year: 1981 ident: e_1_2_5_3_1 article-title: Assessment of liver iron content in 271 patients publication-title: a reevaluation of direct and indirect methods – ident: e_1_2_5_4_1 doi: 10.1046/j.1365-2141.2003.04516.x – ident: e_1_2_5_21_1 doi: 10.1126/science.1104742 – ident: e_1_2_5_24_1 doi: 10.1172/JCI0215686 – ident: e_1_2_5_22_1 doi: 10.1182/blood-2002-10-3235 – ident: e_1_2_5_25_1 doi: 10.1038/ng1150 – ident: e_1_2_5_16_1 doi: 10.1182/blood-2003-07-2524 – ident: e_1_2_5_29_1 doi: 10.1074/jbc.M008923200 – ident: e_1_2_5_26_1 doi: 10.1111/acer.1998.22.s3_part1.145s – ident: e_1_2_5_2_1 doi: 10.1016/S0140-6736(03)12602-5 – ident: e_1_2_5_12_1 doi: 10.1016/S0014-5793(00)01920-7 – ident: e_1_2_5_32_1 doi: 10.1515/CCLM.2004.069 – ident: e_1_2_5_11_1 doi: 10.1097/01.alc.0000189274.00479.62 – ident: e_1_2_5_6_1 doi: 10.1007/BF02255967 – ident: e_1_2_5_7_1 doi: 10.1182/blood-2003-03-0672 – ident: e_1_2_5_23_1 doi: 10.1073/pnas.151179498 – ident: e_1_2_5_31_1 doi: 10.1111/j.1530-0277.2002.tb02698.x – ident: e_1_2_5_19_1 doi: 10.1172/JCI200420945 – ident: e_1_2_5_27_1 doi: 10.1074/jbc.M008922200 – ident: e_1_2_5_30_1 doi: 10.1111/j.1530-0277.2004.tb03225.x – volume: 30 start-page: 107 year: 2003 ident: e_1_2_5_37_1 article-title: Iron‐dependent activation of NF‐kappaB in Kupffer cells publication-title: a priming mechanism for alcoholic liver disease – ident: e_1_2_5_28_1 doi: 10.1053/j.gastro.2004.11.057 – ident: e_1_2_5_17_1 doi: 10.1016/S0026-0495(03)00277-4 – volume: 53 start-page: 735 year: 2004 ident: e_1_2_5_13_1 article-title: Pro‐hepcidin publication-title: expression and cell specific localization in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia – ident: e_1_2_5_14_1 doi: 10.1073/pnas.0409808102 – ident: e_1_2_5_18_1 doi: 10.1002/hep.20620 – ident: e_1_2_5_9_1 doi: 10.1002/hep.1840220441 – ident: e_1_2_5_10_1 doi: 10.1182/blood-2004-04-1416 – volume: 28 start-page: 137 year: 1993 ident: e_1_2_5_33_1 article-title: Characteristic features of alcoholic liver disease in Japan publication-title: a review – ident: e_1_2_5_20_1 doi: 10.1182/blood-2004-08-3042 – ident: e_1_2_5_34_1 doi: 10.1172/JCI118077 – ident: e_1_2_5_35_1 doi: 10.1111/j.1530-0277.1996.tb01134.x |
SSID | ssj0004866 |
Score | 2.1634707 |
Snippet | Background: It is common for alcoholic patients to have excess iron accumulation in the liver, which may contribute to the development of alcoholic liver... Background: It is common for alcoholic patients to have excess iron accumulation in the liver, which may contribute to the development of alcoholic liver... It is common for alcoholic patients to have excess iron accumulation in the liver, which may contribute to the development of alcoholic liver disease (ALD).... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | S2 |
SubjectTerms | Alcoholic Liver Disease Animals Antimicrobial Cationic Peptides - blood Antimicrobial Cationic Peptides - genetics Down-Regulation - genetics Ethanol Ferritins - blood Hemosiderosis - blood Hemosiderosis - genetics Hemosiderosis - pathology Hepcidin Hepcidins Humans Intestinal Absorption - genetics Iron Iron - blood Iron Overload - blood Iron Overload - genetics Iron Overload - pathology Liver - metabolism Liver Diseases, Alcoholic - blood Liver Diseases, Alcoholic - genetics Liver Diseases, Alcoholic - pathology Macrophages - metabolism Male Mice Mice, Inbred C57BL Protein Precursors - genetics Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - genetics |
Title | Hepcidin Is Down-Regulated in Alcohol Loading |
URI | https://api.istex.fr/ark:/67375/WNG-PJN0VPFL-N/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1530-0277.2006.00279.x https://www.ncbi.nlm.nih.gov/pubmed/17331161 https://www.proquest.com/docview/70222084 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9tAEB4heuFCH5TWlMceKm5O7WTt3T1GlDQgGqGI123lfRihoATlIaGe-hP6G_tLOuONA6k4IMTNsjX27s6M55ud2RmAr6gyBSGFmIqfoIOCPmvR5BJl2RU-LWVuSzqc_LOXd8_58VV2Nc9_orMwoT7EYsONNKP6X5OCF2ayrORZK6likHVMoSlUg_AkpW4RPuo_VJLiMoQtU57FaOPlclLPky9aslRvaNHvn4Khy6i2MkudtzCoJxSyUQaN2dQ07K__aj2-zozfwfocvbJ2ELf3sOKHH2A7HPFll_62LMae7bP6xmg82IBvXX9nb9BEsqMJ-45O_9_ff_r-mtqGecfwdjt06WUnoyqf_yOcdw7PDrrxvE1DbNGyqRg1nCfS4VB85gVHfGWcRxjhkf2llMh6xUuRU5ef1Kb4lGeOZ6VqGWdUaW1rE1aHo6H_DMwIJ0XLWeuF42mRqWaijFfWlLlVMjERiJol2s5rmFMrjVv9yJfBNdK0RtRhk3L2cGD6PoJ0QXkX6ng8g2a_4vqCoBgPKA9OZPqy90OfHveSi9POie5FsFeLhUbtpJBLMfSj2UQL8qcTySP4FKTl4ePULBPhdgR5xfNnj0q3Dw77eLX1UsIvsBY2qGkfaRtWp-OZ30FkNTW7lc78A6tqEBg |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEB6h9gAXoDwNpd0D6s3BTtbe3WNUmqYltaqopb2tvA8jlCip0kSqOPET-I38Ema8cdqgHirEzbI19j5mPN_szs4H8BFNpiSkEFPxEwxQMGYt21yiLrvSp5XMbUWHk0-KvH_Ojy-zyyUdEJ2FCfUhVgtuZBn1_5oMnBak16086yT1JmSzqdAWqoWAcpMIvuv4anhbS4rLsHGZ8ixGLy_X03rufdOar9qkYb-5D4iu49raMfWewbjpUshHGbUWc9OyP_6q9vif-vwcni4BLOsGjduCR37yArbDKV924cdVOfNsjzU3prPRS_jU91f2O3pJdnTNPmPc__vnr6H_Rsxh3jG83Q1EvWwwrVP6X8F57-Bsvx8vmRpii85NxWjkPJEOm-IzLzhCLOM8IgmPGlBJibOveCVyIvpJbYpPeeZ4VqmOcUZV1nZew8ZkOvFvgRnhpOg4a71wPC0z1U6U8cqaKrdKJiYC0cyJtssy5sSmMdZ3whkcI01jRCSblLaHDdM3EaQryatQyuMBMnv1tK8EytmIUuFEpi-KQ316XCRfT3sDXUSw2-iFRgOlXZdy4qeLay0opE4kj-BNUJfbjxNfJiLuCPJ60h_cKt3dPxji1bt_FdyFx_2zk4EeHBVf3sOTsF5Ny0rbsDGfLfwHBFpzs1Mb0B_ETRQz |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9swDCaGFhh22fvhrVt1GHpzZieyJR2DplnaZUYQrGtvgq1HMaRIgjQBip32E_Yb90tGWnG6DD0Uw26GDdqSSJofRYoEeI8qUxJSiKn4CToo6LOWbS5Rlm3pUi9z4-lw8uciH5zyk_PsfJ3_RGdhQn2IzYYbaUb9vyYFn1u_reRZJ6ljkE1MoS1UC_HkLs8TSRLeG9-UkuIyxC1TnsVo5OV2Vs-tb9oyVbu06te34dBtWFvbpf4jmDQzCukok9ZqWbXM97-KPf6fKT-Gh2v4yrpB3p7APTd9CnvhjC87c5e-XDh2wJobs8XkGXwYuLn5hjaSHV-xHnr9v378HLsL6hvmLMPb3dCmlw1ndUL_czjtH305HMTrPg2xQdOmYlRxnkiLQ3GZExwBVmUd4giH_PdSIu8V9yKnNj-pSfEpzyzPvOpUtlLemM4L2JnOpu4VsEpYKTrWGCcsT8tMtRNVOWUqnxslkyoC0bBEm3URc-qlcan_cGZwjTStEbXYpKQ9HJi-jiDdUM5DIY870BzUXN8QlIsJJcKJTJ8VH_XopEi-jvpDXUSw34iFRvWkmEs5dbPVlRbkUCeSR_AySMvNx6lbJuLtCPKa53cele4eHo3x6vW_Eu7D_VGvr4fHxac38CBsVtOe0h7sLBcr9xZR1rJ6V6vPb3lzEus |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepcidin+Is+Down-Regulated+in+Alcohol+Loading&rft.jtitle=Alcoholism%2C+clinical+and+experimental+research&rft.au=Ohtake%2C+Takaaki&rft.au=Saito%2C+Hiroyuki&rft.au=Hosoki%2C+Yayoi&rft.au=Inoue%2C+Mitsutaka&rft.date=2007-01-01&rft.pub=Blackwell+Publishing+Inc&rft.issn=0145-6008&rft.eissn=1530-0277&rft.volume=31&rft.issue=s1&rft.spage=S2&rft.epage=S8&rft_id=info:doi/10.1111%2Fj.1530-0277.2006.00279.x&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_PJN0VPFL_N |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0145-6008&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0145-6008&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0145-6008&client=summon |